EGFR and adenocarcinoma: Interestingly, following treatment with erlotinib in combination with the WT1/MUC1-DC vaccine, the tumor was undetectable by CT analysis for at least 587 days after treatment in a patient with lung cancer with EGFR-mutated adenocarcinoma.